B/BE/25/BVW2 - Fiche d'information destinée au public (préparée par le notifiant)

File: 
PDF icon bbe25bvw2_pub_fr.pdf
Trial reference: 
A randomised, double-blind, placebo-controlled, single centre, Phase I study to evaluate the safety, reactogenicity and immunogenicity of AstriVax’ investigational therapeutic hepatitis B virus (HBV) vaccine (AVX70371) in healthy adults aged 18 to 40 year
Doc type: 
Information for the public